☆ 4.7 Article

Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients

LEUKEMIA (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Biophysics

Non-T depleted haploidentical stem cell transplantation in AML patients achieving first complete remission after one versus two induction courses: a study from the ALWP/EBMT

Arnon Nagler et al.

Summary: This study compared the transplantation outcomes of AML patients undergoing HaploSCT in CR1 after one or two induction chemotherapy courses. The results showed that patients achieving CR1 with two induction courses had a higher relapse incidence and inferior leukemia-free survival, overall survival, and GVHD-free, relapse-free survival compared to those achieving CR1 with one induction course.

BONE MARROW TRANSPLANTATION (2022)

添加到收藏夹

Review Hematology

Hematopoietic Cell Transplantation in the Treatment of Newly Diagnosed Adult Acute Myeloid Leukemia: An Evidence-Based Review from the American Society of Transplantation and Cellular Therapy

Bhagirathbhai Dholaria et al.

Summary: This evidence-based review examines the role of hematopoietic cell transplantation (HCT) in the management of newly diagnosed adult acute myeloid leukemia (AML) and recommends the preferential use of allogeneic HCT with myeloablative conditioning in eligible patients. Allogeneic HCT offers a survival benefit in intermediate- and high-risk AML patients and is now considered part of standard clinical care.

TRANSPLANTATION AND CELLULAR THERAPY (2021)

添加到收藏夹

Article Hematology

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

Michael Heuser et al.

Summary: The European LeukemiaNet MRD Working Party updated the 2018 MRD recommendations, including technical specifications and integrative assessments. They also proposed the use of MRD as a prognostic and surrogate endpoint for drug testing, as well as the clinical implications of MRD assessment in AML. Recommendations include technical requirements for flow cytometry and molecular MRD analysis, as well as reporting methods for MRD results.

BLOOD (2021)

添加到收藏夹

Article Oncology

Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia

Charles Craddock et al.

Summary: The intensified RIC conditioning regimen, FLAMSA-Bu, did not improve outcomes for adults undergoing transplantation for high-risk AML or MDS, regardless of pretransplant MRD status. Pretransplant detectable MRD was associated with disease relapse, but acquisition of full donor T-cell chimerism improved overall survival.

JOURNAL OF CLINICAL ONCOLOGY (2021)

添加到收藏夹

Article Biophysics

Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation

Mary-Elizabeth Percival et al.

Summary: The study found that in AML patients, those in CRi had increased risk of death compared to those in CR, along with higher non-relapse mortality, shorter disease-free survival, and increased relapse. Detectable MRD was associated with shorter overall survival, shorter disease-free survival, higher non-relapse mortality, and increased relapse. The detrimental effects of CRi and MRD were independent.

BONE MARROW TRANSPLANTATION (2021)

添加到收藏夹

Article Oncology

Impact of Conditioning Intensity of Allogeneic Transplantation for Acute Myeloid Leukemia With Genomic Evidence of Residual Disease

Christopher S. Hourigan et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

添加到收藏夹

Article Oncology

Second cycle remission achievement with 7+3 and survival in adults with newly diagnosed acute myeloid leukemia: analysis of recent SWOG trials

Megan Othus et al.

LEUKEMIA (2019)

添加到收藏夹

Article Hematology

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

Gerrit J. Schuurhuis et al.

BLOOD (2018)

添加到收藏夹

Review Medicine, General & Internal

Acute myeloid leukaemia

Nicholas J. Short et al.

LANCET (2018)

添加到收藏夹

Review Hematology

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

Hartmut Doehner et al.

BLOOD (2017)

添加到收藏夹

Article Hematology

Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis

Sarah A. Buckley et al.

HAEMATOLOGICA (2017)

添加到收藏夹

Article Hematology

Minimal residual disease prior to allogeneic hematopoietic cell transplantation in acute myeloid leukemia: a meta-analysis

Sarah A. Buckley et al.

HAEMATOLOGICA (2017)

添加到收藏夹

Article Oncology

Allogeneic Transplantation for Advanced Acute Myeloid Leukemia: The Value of Complete Remission

Daniel J. Weisdorf et al.

CANCER (2017)

添加到收藏夹

Article Oncology

Cytogenetic Risk Determines Outcomes After Allogeneic Transplantation in Older Patients With Acute Myeloid Leukemia in Their Second Complete Remission: A Center for International Blood and Marrow Transplant Research Cohort Analysis

Fotios V. Michelis et al.

CANCER (2017)

添加到收藏夹

Article Hematology

An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation

Paul Ferguson et al.

HAEMATOLOGICA (2016)

添加到收藏夹

Article Hematology

An operational definition of primary refractory acute myeloid leukemia allowing early identification of patients who may benefit from allogeneic stem cell transplantation

Paul Ferguson et al.

HAEMATOLOGICA (2016)

添加到收藏夹

Article

Number of Courses of Induction Therapy Independently Predicts Outcome after Allogeneic Transplantation for Acute Myeloid Leukemia in First Morphological Remission

Roland B. Walter et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)

添加到收藏夹

Article Hematology

Effect of Postremission Therapy before Reduced-Intensity Conditioning Allogeneic Transplantation for Acute Myeloid Leukemia in First Complete Remission

Erica D. Warlick et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)

添加到收藏夹

Article Oncology

Impact of Postremission Consolidation Chemotherapy on Outcome After Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation for Patients With Acute Myeloid Leukemia in First Complete Remission

Moshe Yeshurun et al.

CANCER (2014)

添加到收藏夹

Article Oncology

Pre-transplant consolidation chemotherapy may not improve outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remission

Steven E. McCormack et al.

LEUKEMIA RESEARCH (2011)

添加到收藏夹

Article Oncology

Adult Patients With Acute Myeloid Leukemia Who Achieve Complete Remission After 1 or 2 Cycles of Induction Have a Similar Prognosis A Report on 1980 Patients Registered to 6 Studies Conducted by the Eastern Cooperative Oncology Group

Jacob M. Rowe et al.

CANCER (2010)

添加到收藏夹

Article Oncology

Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure

Michel Duval et al.

JOURNAL OF CLINICAL ONCOLOGY (2010)

添加到收藏夹

Article Hematology

Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant Research

Sergio Giralt et al.

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)

添加到收藏夹

Review Medicine, General & Internal

Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission Systematic Review and Meta-analysis of Prospective Clinical Trials

John Koreth et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)

添加到收藏夹

Article Hematology

No impact of high-dose cytarabine on the outcome of patients transplanted for acute myeloblastic leukaemia in first remission

JY Cahn et al.

BRITISH JOURNAL OF HAEMATOLOGY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.